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Background
Leukocytospermia is defined as presence of ≥1 x 106
WBC/mL of the seminal ejaculate. The World Health
Organization (WHO) recommends peroxidase staining as
the standard method for the detection of semen leukocytes
[1,2]. The incidence of leukocytospermia ranges from 10 -
20% among infertile men. Both morphologically abnormal
spermatozoa and leukocytes produce reactive oxygen spe-
cies (ROS). The polymorphonuclear neutrophils and
macrophages are the main components of seminal leuko-
cytes which can generate significantly higher (>100-fold)
quantities of ROS, overwhelming the ROS-scavenging
mechanisms in seminal plasma and resulting in oxidative
stress and damage to spermatozoa. The presence of very
few activated leukocytes can produce a detectable amount
of ROS [3,4]. Therefore, even a very low number of leuko-
cytes in the sperm suspension may influence the integrity
of sperm and, consequently, the outcome of assisted
reproduction treatment [5]. Leukocytes contributed
directly to ROS production and release and indirectly
through the leukocyte-stimulated sperm. Such stimulation
may be via direct contact or mediated by soluble products
released by the leukocytes. The goal of our study was to
assess the effect of low level leukocytospermia on semen
quality and oxidative stress markers in infertile men.
Materials and methods
In this prospective study, 211 infertile patients with no
history of genital tract infections or varicocele were
included. Semen samples were examined for sperm con-
centration, motility, seminal leukocyte levels (Endtz test)
[2], reactive oxygen species (ROS) by chemilumines-
cence assay, and sperm DNA damage by TUNEL test.
Patients were divided into 3 groups based on their semi-
nal leukocyte levels. Group 1: no seminal leukocytes (n
= 153); group 2: low level leukocytospermia (0.1 -1 X
106 WBC/mL; n = 22); and group 3: leukocytospermia
(>1 X 106 WBC/mL; n = 36).
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Table 1 Semen parameters and its association with leukocytospermia
Parameters Seminal leukocytes (X 106 WBC/mL)
No leukocytes 0.1 – 1 WBC > 1 WBC
Concentration (X 106/mL) 53.04 ± 56.76 69.04 ± 80.72 39.35 ± 39.98
Motility (%) 48.37 ± 17.42 47.33 ± 25.74 49.23 ± 19.56
Normal morphology (%) 3.42 ± 3.12 3.56 ± 3.16 4.14 ± 3.79
ROS (RLU/ sec) 116.7 (49; 550.3) 944.8 (127; 3315.4)a 61286.8 (6905; 234876)a,b
DNA damage (%) 19.89 ± 17.31 26.47 ± 19.64a 24.60 ± 17.47
Results are presented as mean ± SD for all the parameters except ROS which is presented as median (25th; 75th percentile).
aP <0.05 statistically significant compared to non leukocytospermic group.
bP <0.05 statistically significant compared to low level leukocytospermic group.
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Results
22 patients (10%) had high and 36 (18.3%) had low semi-
nal leukocytes levels (Table 1). Conventional semen para-
meters between the 3 groups were similar. Patients with
low level leukocytospermia had significantly higher levels
of ROS (P = 0.001) and sperm DNA damage (P <0.05)
compared to non leukocytospermic group. There was no
significant difference in ROS levels between the two
groups of leukocytospermia (groups 2 and 3).
Conclusions
Patients presenting with low levels of leukocytes have a
high oxidative stress. Although these patients are not cate-
gorised as leukocytospermic by current WHO guidelines,
however these men may benefit by treatment with antibio-
tics or antioxidant supplements to reduce ROS induced
sperm DNA damage and improve therefore their chances
of fertility.
Authors’ details
1Center for Reproductive Medicine, Cleveland Clinic, Cleveland, Ohio 44195,
USA. 2Salman Bin Abdulaziz University, College of Medicine, Saudi Arabia.
3Center of Excellence in Genomic Medicine Research, KAU, Saudi Arabia.
4KACST Technology Innovation Center for Personalized Medicine, King
Abdulaziz University, Jeddah, Saudi Arabia.
Published: 2 April 2014
References
1. World Health Organization: WHO Laboratory manual for the examination
of human semen and sperm-cervical mucus interaction. Cambridge,
Cambridge University Press;, 4th 1999.
2. World Health Organization: WHO laboratory manual for the examination
and processing of human semen. Geneva, Switzerland;, Fifth 2010.
3. Plante M, de Lamirande E, Gagnon C: Reactive oxygen species released
by activated neutrophils, but not by deficient spermatozoa, are
sufficient to affect normal sperm motility. Fertil Steril 1994, 62:387-393.
4. Sharma R, Pasqualotto F, Nelson D, Thomas A, Agarwal A: Relationship
between seminal white blood cells counts and oxidative stress in men
treated at an infertility clinic. J Androl 2001, 22:575-583.
5. Henkel R, Kierspel E, Stalf T, Mehnert C, Menkveld R, Tinneberg HR,
Schill WB, Kruger TF: Effect of reactive oxygen species produced by
spermatozoa and leukocytes on sperm functions in non-
leukocytospermic patients. Fertil Steril 2005, 83:635-642.
doi:10.1186/1471-2164-15-S2-P56
Cite this article as: Alshahrani et al.: The effect of low level
leukocytospermia on oxidative stress markers in infertile men. BMC
Genomics 2014 15(Suppl 2):P56.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color figure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
Alshahrani et al. BMC Genomics 2014, 15(Suppl 2):P56
http://www.biomedcentral.com/1471-2164/15/S2/P56
Page 2 of 2
